Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide is taken once a week, on the same chosen day each week, by subcutaneous injection — that frequency never changes regardless of which dose you are on. You will find that how often you take tirzepatide stays fixed at weekly throughout the entire treatment period, while the amount per injection is what the prescriber gradually adjusts. Because tirzepatide is a prescription-only medicine, the schedule is set during a clinical assessment rather than chosen by the patient — a real prescriber reviews your circumstances and decides which dose is appropriate and when to move it up.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The once-weekly interval is not an arbitrary preference; it follows tirzepatide's pharmacokinetics. The medicine has a half-life of roughly five days, which means a weekly injection keeps plasma levels within a stable therapeutic range without the peaks and troughs that a daily drug can produce. Take it on a Monday, and the following Monday is your next dose, that rhythm holds at 2.5 mg just as it does at 15 mg.
Practically, this matters in two ways. First, you can pick whichever day of the week fits your routine best, many people choose a day when they are at home and unhurried. Second, if you need to shift the day by a day or two, that is something to discuss with your prescriber rather than decide alone, because the gap between doses affects how the medicine behaves. The Mounjaro overview at nume has more on how tirzepatide works as a dual GIP and GLP-1 receptor agonist, if you want the mechanism detail.
One thing worth knowing early: the total number of injections per prescription period stays constant. Each KwikPen contains four pre-measured doses, so a monthly supply is one pen.
Here is where a lot of confusion arises. When people ask how often to take tirzepatide, they sometimes mean how often the dose changes, and that is a different question from how often the injection is given.
The injection is always weekly. The dose, however, is reviewed and potentially increased at roughly four-week intervals, starting at 2.5 mg. That first pen's job is almost entirely about helping your system adjust, the gastrointestinal effects of starting a GLP-1/GIP medicine are real, and the lower starting dose exists precisely to reduce their intensity. After four weeks at 2.5 mg most prescribers will assess whether you are tolerating it well before moving to 5 mg, then 7.5 mg, and so on up to the maximum of 15 mg.
Crucially, the decision to increase is clinical, not automatic. A prescriber at a service like ours reviews current weight, tolerance, any side effects reported, and overall progress before any dose change. You can read more about the frequency question from a Mounjaro-specific angle on our page covering how often Mounjaro is taken for weight loss.
If four weeks at a given dose brings on side effects that haven't settled, staying at that dose for longer (rather than pushing upward) is a legitimate and common path. Our guide on how often you take Mounjaro explains how that decision sits within the broader titration process. The maximum licensed dose is 15 mg once weekly; there is no approved dose above that.
Consistency on the chosen day of the week is the practical goal. NHS guidance confirms tirzepatide as a once-weekly injection, and the NHS tirzepatide medicines page is the clearest patient-level summary of what the schedule involves.
If a dose is missed, whether to take it late or skip to the next scheduled day depends on how much time has elapsed, and the answer your prescriber and the Patient Information Leaflet give you will be more accurate than any general rule here, because individual circumstances vary. What is settled guidance: never take two doses on the same day to catch up. Doubling up does not accelerate weight loss; it meaningfully increases the likelihood of nausea, vomiting and other gastrointestinal effects.
Storage also touches timing: the KwikPen is kept refrigerated between 2°C and 8°C, taken out ahead of the injection to reach a comfortable temperature. The SmPC published on the Electronic Medicines Compendium gives the exact room-temperature window, it is worth reading before travel or any planned time away from a fridge.
No. Once-weekly is the licensed dosing frequency for tirzepatide in the UK, full stop. There is no approved twice-weekly variant, no loading-dose phase that involves more frequent injections, and no maintenance phase where the interval widens. For a closer look at this, our page on Mounjaro how often it should be taken walks through why the weekly schedule holds from the first injection right through to the dose you stabilise on.
What can change is the duration: if a full six months at the highest tolerated dose produces less than 5% weight reduction, NICE guidance suggests reviewing whether to continue. That is a conversation between you and your prescriber, not a self-assessment. If you are thinking about what private treatment actually costs alongside this schedule, our Mounjaro pricing page sets out the context honestly, the cost reflects a monthly pen plus the clinical oversight that a prescription medicine requires.
If you are curious whether tirzepatide's dosing frequency suits your lifestyle better than an alternative, our page on how often you should take Mounjaro covers what to consider when fitting the weekly schedule around your routine. And if you are ready to have a prescriber look at your specific situation, the place to start is a free consultation, no waiting list, reviewed the same day by a GPhC-registered prescriber.
Speak to our prescribers about whether tirzepatide fits your circumstances.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.